HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$4.65
Day range
$4.65 - $4.66
Year range
$3.34 - $7.12
Market cap
148.27M CAD
Avg Volume
13.07K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 15.86M | 1.20% |
Operating expense | 13.05M | -21.66% |
Net income | -5.40M | 15.99% |
Net profit margin | -34.05 | 16.97% |
Earnings per share | -0.17 | 11.92% |
EBITDA | 5.88M | 31.23% |
Effective tax rate | -1.41% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.95M | 5.93% |
Total assets | 209.06M | -13.49% |
Total liabilities | 111.36M | -4.27% |
Total equity | 97.70M | — |
Shares outstanding | 31.92M | — |
Price to book | 1.52 | — |
Return on assets | -1.30% | — |
Return on capital | -1.46% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.40M | 15.99% |
Cash from operations | 3.73M | 6.05% |
Cash from investing | -14.00K | 30.00% |
Cash from financing | -3.89M | 5.08% |
Net change in cash | 144.00K | 125.90% |
Free cash flow | 5.10M | -33.01% |
About
Founded
2014
Website
Employees
91